{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:40:15Z","timestamp":1778539215699,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10875-022-01256-y","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T19:02:31Z","timestamp":1648926151000},"page":"914-922","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7422-1453","authenticated-orcid":false,"given":"Sudhir","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhanshu","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houfen","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesim","family":"Demirdag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,2]]},"reference":[{"issue":"6","key":"1256_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"QX Long","year":"2020","unstructured":"Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26(6):845\u20138.","journal-title":"Nat Med"},{"issue":"6","key":"1256_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.immuni.2020.04.023","volume":"52","author":"L Ni","year":"2020","unstructured":"Ni L, Ye F, Cheng ML, Feng Y, Deng YQ, Zhao H, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52(6):971-7 e3.","journal-title":"Immunity."},{"key":"1256_CR3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3389\/fimmu.2020.01049","volume":"11","author":"G Siracusano","year":"2020","unstructured":"Siracusano G, Pastori C, Lopalco L. Humoral immune responses in COVID-19 patients: a window on the state of the art. Front Immunol. 2020;11:1049.","journal-title":"Front Immunol"},{"issue":"6521","key":"1256_CR4","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1126\/science.abd7728","volume":"370","author":"A Wajnberg","year":"2020","unstructured":"Wajnberg A, Amanat F, Firpo A, Altman DR, Bailey MJ, Mansour M, et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020;370(6521):1227\u201330.","journal-title":"Science"},{"issue":"12","key":"1256_CR5","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","volume":"21","author":"MC Woodruff","year":"2020","unstructured":"Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol. 2020;21(12):1506\u201316.","journal-title":"Nat Immunol"},{"issue":"16","key":"1256_CR6","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","volume":"71","author":"J Zhao","year":"2020","unstructured":"Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2027\u201334.","journal-title":"Clin Infect Dis"},{"key":"1256_CR7","doi-asserted-by":"publisher","first-page":"633184","DOI":"10.3389\/fimmu.2021.633184","volume":"12","author":"M Chvatal-Medina","year":"2021","unstructured":"Chvatal-Medina M, Mendez-Cortina Y, Patino PJ, Velilla PA, Rugeles MT. Antibody responses in COVID-19: a review. Front Immunol. 2021;12:633184.","journal-title":"Front Immunol."},{"issue":"1","key":"1256_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","volume":"22","author":"SP Weisberg","year":"2021","unstructured":"Weisberg SP, Connors TJ, Zhu Y, Baldwin MR, Lin WH, Wontakal S, et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol. 2021;22(1):25\u201331.","journal-title":"Nat Immunol"},{"issue":"25","key":"1256_CR9","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","volume":"383","author":"EJ Anderson","year":"2020","unstructured":"Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med. 2020;383(25):2427\u201338.","journal-title":"N Engl J Med"},{"issue":"5","key":"1256_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403\u201316.","journal-title":"N Engl J Med"},{"issue":"7830","key":"1256_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","volume":"586","author":"U Sahin","year":"2020","unstructured":"Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020;586(7830):594\u20139.","journal-title":"Nature"},{"issue":"7","key":"1256_CR12","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s10875-021-01077-5","volume":"41","author":"LM Castano-Jaramillo","year":"2021","unstructured":"Castano-Jaramillo LM, Yamazaki-Nakashimada MA, O\u2019Farrill-Romanillos PM, MuzquizZermeno D, Scheffler Mendoza SC, Venegas Montoya E, et al. COVID-19 in the context of inborn errors of immunity: a case series of 31 patients from Mexico. J Clin Immunol. 2021;41(7):1463\u201378.","journal-title":"J Clin Immunol"},{"issue":"7","key":"1256_CR13","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s10875-021-01065-9","volume":"41","author":"S Esenboga","year":"2021","unstructured":"Esenboga S, Ocak M, Akarsu A, Bildik HN, Cagdas D, Iskit AT, et al. COVID-19 in patients with primary immunodeficiency. J Clin Immunol. 2021;41(7):1515\u201322.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1256_CR14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaip.2020.09.052","volume":"9","author":"HE Ho","year":"2021","unstructured":"Ho HE, Mathew S, Peluso MJ, Cunningham-Rundles C. Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City. J Allergy Clin Immunol Pract. 2021;9(1):490-3 e2.","journal-title":"J Allergy Clin Immunol Pract."},{"key":"1256_CR15","doi-asserted-by":"publisher","first-page":"614086","DOI":"10.3389\/fimmu.2020.614086","volume":"11","author":"N Marcus","year":"2020","unstructured":"Marcus N, Frizinsky S, Hagin D, Ovadia A, Hanna S, Farkash M, et al. Minor clinical impact of COVID-19 pandemic on patients with primary immunodeficiency in Israel. Front Immunol. 2020;11:614086.","journal-title":"Front Immunol."},{"issue":"2","key":"1256_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jaci.2020.09.010","volume":"147","author":"I Meyts","year":"2021","unstructured":"Meyts I, Bucciol G, Quinti I, Neven B, Fischer A, Seoane E, et al. Coronavirus disease 2019 in patients with inborn errors of immunity: an international study. J Allergy Clin Immunol. 2021;147(2):520\u201331.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"1256_CR17","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1016\/j.jaip.2021.04.017","volume":"9","author":"C Milito","year":"2021","unstructured":"Milito C, Lougaris V, Giardino G, Punziano A, Vultaggio A, Carrabba M, et al. Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity. J Allergy Clin Immunol Pract. 2021;9(7):2904-6 e2.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"1","key":"1256_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jaci.2020.04.013","volume":"146","author":"I Quinti","year":"2020","unstructured":"Quinti I, Lougaris V, Milito C, Cinetto F, Pecoraro A, Mezzaroma I, et al. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. J Allergy Clin Immunol. 2020;146(1):211-3 e4.","journal-title":"J Allergy Clin Immunol."},{"issue":"3","key":"1256_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","volume":"147","author":"AM Shields","year":"2021","unstructured":"Shields AM, Burns SO, Savic S, Consortium UPC-. Richter AG COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. J Allergy Clin Immunol. 2021;147(3):870-5 e1.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"1256_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/pai.13263","volume":"31","author":"A Soresina","year":"2020","unstructured":"Soresina A, Moratto D, Chiarini M, Paolillo C, Baresi G, Foca E, et al. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Pediatr Allergy Immunol. 2020;31(5):565\u20139.","journal-title":"Pediatr Allergy Immunol"},{"issue":"9","key":"1256_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41577-020-0402-6","volume":"20","author":"Z Chen","year":"2020","unstructured":"Chen Z, John WE. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020;20(9):529\u201336.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1256_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.it.2020.11.002","volume":"42","author":"P de Candia","year":"2021","unstructured":"de Candia P, Prattichizzo F, Garavelli S, Matarese G. T cells: warriors of SARS-CoV-2 infection. Trends Immunol. 2021;42(1):18\u201330.","journal-title":"Trends Immunol"},{"key":"1256_CR23","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3389\/fimmu.2020.01662","volume":"11","author":"A Guihot","year":"2020","unstructured":"Guihot A, Litvinova E, Autran B, Debre P, Vieillard V. Cell-mediated immune responses to COVID-19 infection. Front Immunol. 2020;11:1662.","journal-title":"Front Immunol"},{"issue":"7821","key":"1256_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","volume":"584","author":"N Le Bert","year":"2020","unstructured":"Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584(7821):457\u201362.","journal-title":"Nature"},{"key":"1256_CR25","doi-asserted-by":"crossref","unstructured":"Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508).","DOI":"10.1126\/science.abc8511"},{"issue":"9","key":"1256_CR26","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1172\/JCI138554","volume":"130","author":"A Mazzoni","year":"2020","unstructured":"Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020;130(9):4694\u2013703.","journal-title":"J Clin Invest"},{"issue":"1","key":"1256_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","volume":"22","author":"A Nelde","year":"2021","unstructured":"Nelde A, Bilich T, Heitmann JS, Maringer Y, Salih HR, Roerden M, et al. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nat Immunol. 2021;22(1):74\u201385.","journal-title":"Nat Immunol"},{"key":"1256_CR28","doi-asserted-by":"crossref","unstructured":"Weiskopf D, Schmitz KS, Raadsen MP, Grifoni A, Okba NMA, Endeman H, et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol. 2020;5(48).","DOI":"10.1126\/sciimmunol.abd2071"},{"issue":"1","key":"1256_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41392-020-00263-y","volume":"5","author":"F Zhang","year":"2020","unstructured":"Zhang F, Gan R, Zhen Z, Hu X, Li X, Zhou F, et al. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals. Signal Transduct Target Ther. 2020;5(1):156.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"1256_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","volume":"17","author":"HY Zheng","year":"2020","unstructured":"Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17(5):541\u20133.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"1256_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000514193","volume":"182","author":"S Gupta","year":"2021","unstructured":"Gupta S, Su H, Narsai T, Agrawal S. SARS-CoV-2-associated T-cell responses in the presence of humoral immunodeficiency. Int Arch Allergy Immunol. 2021;182(3):195\u2013209.","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"1256_CR32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93(3):190\u20137. https:\/\/doi.org\/10.1006\/clim.1999.4799.","journal-title":"Clin Immunol."},{"issue":"6","key":"1256_CR33","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1007\/s10875-021-01046-y","volume":"41","author":"H Kinoshita","year":"2021","unstructured":"Kinoshita H, Durkee-Shock J, Jensen-Wachspress M, Kankate VV, Lang H, Lazarski CA, et al. Robust antibody and T cell responses to SARS-CoV-2 in patients with antibody deficiency. J Clin Immunol. 2021;41(6):1146\u201353.","journal-title":"J Clin Immunol"},{"key":"1256_CR34","doi-asserted-by":"publisher","first-page":"607918","DOI":"10.3389\/fimmu.2020.607918","volume":"11","author":"S Steiner","year":"2020","unstructured":"Steiner S, Sotzny F, Bauer S, Na IK, Schmueck-Henneresse M, Corman VM, et al. HCoV- and SARS-CoV-2 cross-reactive T cells in CVID patients. Front Immunol. 2020;11:607918.","journal-title":"Front Immunol."},{"issue":"1","key":"1256_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2020.12.002","volume":"54","author":"MS Rha","year":"2021","unstructured":"Rha MS, Jeong HW, Ko JH, Choi SJ, Seo IH, Lee JS, et al. PD-1-expressing SARS-CoV-2-specific CD8(+) T cells are not exhausted, but functional in patients with COVID-19. Immunity. 2021;54(1):44-52 e3.","journal-title":"Immunity."},{"issue":"11","key":"1256_CR36","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng Y, Mentzer AJ, Liu G, Yao X, Yin Z, Dong D, et al. Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat Immunol. 2020;21(11):1336\u201345.","journal-title":"Nat Immunol"},{"issue":"12","key":"1256_CR37","doi-asserted-by":"publisher","first-page":"e20200872","DOI":"10.1084\/jem.20200872","volume":"217","author":"Y Jouan","year":"2020","unstructured":"Jouan Y, Guillon A, Gonzalez L, Perez Y, Boisseau C, Ehrmann S, Ferreira M, Daix T, Jeannet R, Fran\u00e7ois B, Dequin PF, Si-Tahar M, Baranek T, Paget C. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients. J Exp Med. 2020;217(12):e20200872. https:\/\/doi.org\/10.1084\/jem.20200872.","journal-title":"J Exp Med"},{"key":"1256_CR38","doi-asserted-by":"publisher","first-page":"610300","DOI":"10.3389\/fimmu.2020.610300","volume":"11","author":"R Carsetti","year":"2020","unstructured":"Carsetti R, Zaffina S, Piano Mortari E, Terreri S, Corrente F, Capponi C, et al. Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases. Front Immunol. 2020;11:610300. https:\/\/doi.org\/10.3389\/fimmu.2020.610300.","journal-title":"Front Immunol"},{"issue":"7","key":"1256_CR39","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","volume":"27","author":"EM Bange","year":"2021","unstructured":"Bange EM, Han NA, Wileyto P, Kim JY, Gouma S, Robinson J, et al. CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat Med. 2021;27(7):1280\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"1256_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","volume":"21","author":"S Xia","year":"2021","unstructured":"Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial. Lancet Infect Dis. 2021;21(1):39\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1256_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","volume":"21","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial. Lancet Infect Dis. 2021;21(2):181\u201392.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"1256_CR42","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s10875-021-01133-0","volume":"41","author":"AF Salinas","year":"2021","unstructured":"Salinas AF, Mortari EP, Terreri S, Quintarelli C, Pulvirenti F, Di Cecca S, et al. SARS-CoV-2 vaccine induced atypical immune responses in antibody defects: everybody does their best. J Clin Immunol. 2021;41(8):1709\u201322.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1256_CR43","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jaci.2021.05.029","volume":"148","author":"D Hagin","year":"2021","unstructured":"Hagin D, Freund T, Navon M, Halperin T, Adir D, Marom R, et al. Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity. J Allergy Clin Immunol. 2021;148(3):739\u201349.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01256-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01256-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01256-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T13:51:10Z","timestamp":1726926670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01256-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,2]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1256"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01256-y","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,2]]},"assertion":[{"value":"17 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee (Institutional Review Board [Human] of University of California at Irvine (HS: 2001\u20132073).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Consent form contains permission to publish data without identifier.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}